297 related articles for article (PubMed ID: 34505767)
1. A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects.
Chakraborty S; DiBerto JF; Faouzi A; Bernhard SM; Gutridge AM; Ramsey S; Zhou Y; Provasi D; Nuthikattu N; Jilakara R; Nelson MNF; Asher WB; Eans SO; Wilson LL; Chintala SM; Filizola M; van Rijn RM; Margolis EB; Roth BL; McLaughlin JP; Che T; Sames D; Javitch JA; Majumdar S
J Med Chem; 2021 Sep; 64(18):13873-13892. PubMed ID: 34505767
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for
Obeng S; Wilkerson JL; León F; Reeves ME; Restrepo LF; Gamez-Jimenez LR; Patel A; Pennington AE; Taylor VA; Ho NP; Braun T; Fortner JD; Crowley ML; Williamson MR; Pallares VLC; Mottinelli M; Lopera-Londoño C; McCurdy CR; McMahon LR; Hiranita T
J Pharmacol Exp Ther; 2021 Mar; 376(3):410-427. PubMed ID: 33384303
[TBL] [Abstract][Full Text] [Related]
3. Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2.
Váradi A; Marrone GF; Palmer TC; Narayan A; Szabó MR; Le Rouzic V; Grinnell SG; Subrath JJ; Warner E; Kalra S; Hunkele A; Pagirsky J; Eans SO; Medina JM; Xu J; Pan YX; Borics A; Pasternak GW; McLaughlin JP; Majumdar S
J Med Chem; 2016 Sep; 59(18):8381-97. PubMed ID: 27556704
[TBL] [Abstract][Full Text] [Related]
4. Interactive Effects of
Obeng S; Leon F; Patel A; Zuarth Gonzalez JD; Chaves Da Silva L; Restrepo LF; Gamez-Jimenez LR; Ho NP; Guerrero Calvache MP; Pallares VLC; Helmes JA; Shiomitsu SK; Soto PL; McCurdy CR; McMahon LR; Wilkerson JL; Hiranita T
J Pharmacol Exp Ther; 2022 Dec; 383(3):182-198. PubMed ID: 36153006
[TBL] [Abstract][Full Text] [Related]
5. Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal.
Wilson LL; Chakraborty S; Eans SO; Cirino TJ; Stacy HM; Simons CA; Uprety R; Majumdar S; McLaughlin JP
Cell Mol Neurobiol; 2021 Jul; 41(5):1131-1143. PubMed ID: 33433723
[TBL] [Abstract][Full Text] [Related]
6. Kratom Alkaloids as Probes for Opioid Receptor Function: Pharmacological Characterization of Minor Indole and Oxindole Alkaloids from Kratom.
Chakraborty S; Uprety R; Daibani AE; Rouzic VL; Hunkele A; Appourchaux K; Eans SO; Nuthikattu N; Jilakara R; Thammavong L; Pasternak GW; Pan YX; McLaughlin JP; Che T; Majumdar S
ACS Chem Neurosci; 2021 Jul; 12(14):2661-2678. PubMed ID: 34213886
[TBL] [Abstract][Full Text] [Related]
7. Predicted Mode of Binding to and Allosteric Modulation of the μ-Opioid Receptor by Kratom's Alkaloids with Reported Antinociception
Zhou Y; Ramsey S; Provasi D; El Daibani A; Appourchaux K; Chakraborty S; Kapoor A; Che T; Majumdar S; Filizola M
Biochemistry; 2021 May; 60(18):1420-1429. PubMed ID: 33274929
[TBL] [Abstract][Full Text] [Related]
8. Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators.
Kruegel AC; Gassaway MM; Kapoor A; Váradi A; Majumdar S; Filizola M; Javitch JA; Sames D
J Am Chem Soc; 2016 Jun; 138(21):6754-64. PubMed ID: 27192616
[TBL] [Abstract][Full Text] [Related]
9. The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats.
Hiranita T; Leon F; Felix JS; Restrepo LF; Reeves ME; Pennington AE; Obeng S; Avery BA; McCurdy CR; McMahon LR; Wilkerson JL
Psychopharmacology (Berl); 2019 Sep; 236(9):2725-2734. PubMed ID: 31098655
[TBL] [Abstract][Full Text] [Related]
10. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
[TBL] [Abstract][Full Text] [Related]
11. Site selective C-H functionalization of Mitragyna alkaloids reveals a molecular switch for tuning opioid receptor signaling efficacy.
Bhowmik S; Galeta J; Havel V; Nelson M; Faouzi A; Bechand B; Ansonoff M; Fiala T; Hunkele A; Kruegel AC; Pintar JE; Majumdar S; Javitch JA; Sames D
Nat Commun; 2021 Jun; 12(1):3858. PubMed ID: 34158473
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus properties of mitragynine (kratom) in rats.
Harun N; Hassan Z; Navaratnam V; Mansor SM; Shoaib M
Psychopharmacology (Berl); 2015 Jul; 232(13):2227-38. PubMed ID: 25616583
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats.
Kamble SH; Obeng S; León F; Restrepo LF; King TI; Berthold EC; Kanumuri SRR; Gamez-Jimenez LR; Pallares VLC; Patel A; Ho NP; Hampson A; McCurdy CR; McMahon LR; Wilkerson JL; Sharma A; Hiranita T
J Pharmacol Exp Ther; 2023 Jun; 385(3):180-192. PubMed ID: 37019472
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive effect of 7-hydroxymitragynine in mice: Discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa.
Matsumoto K; Horie S; Ishikawa H; Takayama H; Aimi N; Ponglux D; Watanabe K
Life Sci; 2004 Mar; 74(17):2143-55. PubMed ID: 14969718
[TBL] [Abstract][Full Text] [Related]
15. Abuse liability of mitragynine assessed with a self-administration procedure in rats.
Yue K; Kopajtic TA; Katz JL
Psychopharmacology (Berl); 2018 Oct; 235(10):2823-2829. PubMed ID: 30039246
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological, and structural explorations of a series of μ-opioid receptor (MOR) agonists with high G protein signaling bias.
Yang Y; Wang Y; Zuo A; Li C; Wang W; Jiang W; Zhang X; Che X; Zhang Y; Wu W; Cen X; Wang H; Tian J
Eur J Med Chem; 2022 Jan; 228():113986. PubMed ID: 34802839
[TBL] [Abstract][Full Text] [Related]
17. Intracerebroventricular administration of CYX-6, a potent μ-opioid receptor agonist, a δ- and κ-opioid receptor antagonist and a biased ligand at μ, δ & κ-opioid receptors, evokes antinociception with minimal constipation and respiratory depression in rats in contrast to morphine.
Imam MZ; Kuo A; Ghassabian S; Cai Y; Qin Y; Li T; Smith MT
Eur J Pharmacol; 2020 Mar; 871():172918. PubMed ID: 31958457
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the rewarding effects of mitragynine and 7-hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats.
Behnood-Rod A; Chellian R; Wilson R; Hiranita T; Sharma A; Leon F; McCurdy CR; McMahon LR; Bruijnzeel AW
Drug Alcohol Depend; 2020 Oct; 215():108235. PubMed ID: 32889450
[TBL] [Abstract][Full Text] [Related]
19. Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine.
Hemby SE; McIntosh S; Leon F; Cutler SJ; McCurdy CR
Addict Biol; 2019 Sep; 24(5):874-885. PubMed ID: 29949228
[TBL] [Abstract][Full Text] [Related]
20. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
